Metraipolis › archive › dc_4cd8578052be

Optimizing vaccine site locations while considering travel inconvenience and public health outcomes — Europe PMC PMID:42440250

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42440250
DOI
10.1007/s10729-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-10-08T03:07:38.492Z
SHA-256 of the archived text
17a8147be75d57327ff37194f4d830145bcacd2593df8c730a42e2b0e3199d0b
Stable URL of this page
https://metraipolis.com/documento/dc_4cd8578052be

How to cite

Optimizing vaccine site locations while considering travel inconvenience and public health outcomes — Europe PMC PMID:42440250 — Europe PMC (en), https://europepmc.org/article/MED/42440250 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cd8578052be (Metraipolis archive dc_4cd8578052be, sha256 17a8147be75d57327ff37194f4d830145bcacd2593df8c730a42e2b0e3199d0b)
BibTeX
@misc{dc4cd8578052be,
  title = {Optimizing vaccine site locations while considering travel inconvenience and public health outcomes — Europe PMC PMID:42440250},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42440250},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cd8578052be; sha256 17a8147be75d57327ff37194f4d830145bcacd2593df8c730a42e2b0e3199d0b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440250. Agents can read the archived copy with the MCP tool read_document.